GLP-1 drugs
3 stories
-
healthGLP-1 Drug Weight Loss Linked to Lower Disease Risk
New study finds significant weight loss from GLP-1 drugs like Ozempic reduces risk of obesity-related conditions including sleep apnea and kidney disease.
-
healthWeight Loss Drugs Linked to Hidden Social Stigma, Study Finds
New research reveals GLP-1 drug users face harsher judgment than those losing weight through diet and exercise.
-
healthWeight-Loss Drugs Show Potential in Reducing Alzheimer's Protein Buildup
A major review suggests popular GLP-1 weight-loss drugs may help limit the molecular hallmarks of Alzheimer's disease, reducing amyloid-beta and tau proteins in preclinical studies.